IDEAYA Biosciences, Inc. (IDYA) financial statements and ratios from SEC XBRL: revenue $218.71M (latest fiscal year), net margin -52.0%, revenue growth 3024.4% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $218.71M |
| Net Margin | -52.0% |
| Revenue Growth (YoY) | 3024.4% |
| EPS Growth (YoY) | -61.9% |
| FCF Growth (YoY) | -70.8% |
| Price / Book | 3.19 |
| Price / Sales | 16.66 |
| FCF Yield | -2.3% |
| Altman Z-Score | 23.65 (safe) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.7 |
IDYA overview · IDYA earnings · IDYA KPIs · IDYA documents · IDYA ownership · IDYA peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.